Study to Assess the Efficacy of Larazotide Acetate for the Treatment of Celiac Disease
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
This study was conducted to evaluate the efficacy of multiple doses of larazotide acetate in
preventing intestinal permeability changes induced by a 6- week gluten challenge in subjects
with celiac disease.